Skip to main content

Nonalcoholic Fatty Liver Disease clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for
  • Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII)

    open to eligible females ages 18-45

    This is a multicenter, phase 2A, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Saroglitazar Magnesium in women with well characterized PCOS.

    San Francisco, California and other locations

  • Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

    Sorry, not yet accepting patients

    The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.

    San Francisco, California and other locations

Last updated: